Review Article
Gliptins and Cardiovascular Outcomes: A Comparative and Critical Analysis after TECOS
Table 1
PROactive primary end-point results [
4].
| | HR (95% CI) |
| Death | 0.96 (0.78–1.18) | Nonfatal MI | 0.83 (0.65–1.06) | Stroke | 0.81 (0.61–1.07) | Major leg amputation | 1.01 (0.58–1.73) | Acute coronary syndrome | 0.78 (0.55–1.11) | Coronary revascularization | 0.88 (0.72–1.08) | Leg revascularization | 1.25 (0.90–1.73) |
|
|